Blood Test for Early Metastatic Diagnosis
March 29, 2022 | Terry Sharrer
“Here, we [University of Oxford researchers] hypothesized that biomarkers within the blood metabolome could identify cancers within a mixed population of patients referred from primary care with nonspecific symptoms, the so-called “low-risk, but not no-risk” patient group, as well as distinguishing between those with and without metastatic disease.” MORE
Image Credit: mdpi.com